Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Поясничная боль: возможности оптимизации терапии
Поясничная боль: возможности оптимизации терапии
П.Р.Камчатнов, М.А.Евзельман. Поясничная боль: возможности оптимизации терапии. Consilium Medicum. Неврология (Прил.). 2013; 2: 23-27.
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Полный текст
Список литературы
1. Kim T, Montejano L, Cao Z, Zhao Y. Health care costs in US patients with and without a diagnosis of osteoarthritis. J Pain Research 2012; 5: 23–30.
2. Hall H, McIntosh G. Low back pain (acute). Clin Evid 2008; 2008: 1102–8.
3. Schneider S, Schmitt H, Zoller S, Schiltenwolf M. Workplace stress, lifestyle and social factors as correlates of back pain: a representative study of the German working population. Int Arch Occup Environ Health 2005; 78 (4): 253–69.
4. Calvo-Muñoz I, Gómez-Conesa A, Meca J. Prevalence of low back pain in children and adolescents: a meta-analysis. 2013; 13: 14–8.
5. Shehab D, Al-Jarallah K. Nonspecific low-back pain in Kuwaiti children and adolescents: associated factors. J Adolesc Health 2005; 36 (1): 32–5.
6. Никифоров А.С., Авакян Г.Н. Неврологические осложнения остеохондроза позвоночника. М.: Медпрактика, 2011.
7. Sharma H, Gupta R, Olivero W et al. fMRI in patients with lumbar disc disease: a paradigm to study patients over time. J Pain Research 2011; 4: 401–5.
8. Hagen K, Jamtvedt G, Hilde G, Winnem M. Bed rest bad for back pain, ineffective for sciatica. The updated Cochrane Review of bed rest for low back pain and sciatica. Spine 2005; 30: 542–6.
9. van Tulder M, Becker A, Bekkering T et al. European guidelines for the management of acute nonspecific low back pain in primary care. J Eur Spine 2006; 15 (Suppl. 2): S169–S191.
10. Acute low back pain: a new paradigm for management. Editorials. BMJ 1996; 313: 1343–4.
11. Pillastrini P, Gardenghi I, Bonetti F et al. An updated overview of clinical guidelines for chronic low back pain management in primary care. Joint Bone Spine 2012; 79 (2): 176–85.
12. Helin-Salmivaara A, Saarelainen S, Gro Nroos J et al. Risk of upper gastrointestinal events with the use of various NSAIDs: A case-control study in a general population. Scandinavian. J Gastroenterol 2007; 42: 923–32.
13. Ding C. Do NSAID affect the progression of osteoarthritis? Inflammation 2002; 26: 139–42.
14. Huskinsson E, Berry P, Gishen P. Effects of anti-inflammatory drugs on the progression of osteoarthritis of the knee. J Rheumatol 1995; 22: 1941–6.
15. Бадокин В.В. Пути оптимизации терапии остеоартроза. Arta medica. 2007; 5 (26): 55–61.
16. Michel B, Bruhlmann P, Stucki G, Uebelhart D. Chondroprotection through Chondrosulf: the Zurich study. Ann Rheum Dis 2002; 61 (Suppl. 1): 116.
17. Lippielo L, Grande D. In vitro chondroprotection of glucosamine and chondroitin sulfate in a rabbit model of a OA and demonstration of metabolic synergy on chondrocyte in vitro. Ann Rheum Dis 2000; 59 (Suppl. 1): 266.
18. Lippielo L, Woodword J, Karpman D еt al. Beneficial effect of cartilage structure modyifing agents tested in chondrocyte and rabbit instability model osteoartrosis. Arthr Rheum 1999; (Suppl. 42): 256.
19. Wilkens P, Scheel I, Grundnes O et al. Effect of glucosamine on pain-related disability in patients with chronic low back pain and degenerative lumbar osteoarthritis: a randomized controlled trial. JAMA 2010; 304 (1): 45–52.
20. Jordan K, Arden N, Doherty M et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Nrials (ESCISIT). Ann Rheum Dis 2003; 62: 1145–55.
21. The efficacy of Glucosamine and Chondroitin Sulfate in Patients with Painful Knee Osteoarthritis (OA): The Glucosamine/chondroitin Arthritis Intervention Trial (GAIT). 2005 ACR/ARHP Annual Sciehtific Meeting, November 12–17, San Diego, California, №622.
22. Чебыкин А.В. Опыт применения хондропротектора Артра у пациентов с болью в спине. Неврология, нейропсихиатрия, психосоматика. 2012; 3: 67–72.
23. Leffler C, Philippi A, Leffler S еt al. Glucosamine, chondroitin, and manganese ascorbate for degenerative joint disease of the knee or low back: a randomized, double-blind, placebo-controlled pilot study. Mil Med 1999; 164 (2): 85–91.
24. Алексеев В.В. Хондропротекторы в неврологии: основания к применению. Cons. Med. 2012; 14; (9): 94–9.
2. Hall H, McIntosh G. Low back pain (acute). Clin Evid 2008; 2008: 1102–8.
3. Schneider S, Schmitt H, Zoller S, Schiltenwolf M. Workplace stress, lifestyle and social factors as correlates of back pain: a representative study of the German working population. Int Arch Occup Environ Health 2005; 78 (4): 253–69.
4. Calvo-Muñoz I, Gómez-Conesa A, Meca J. Prevalence of low back pain in children and adolescents: a meta-analysis. 2013; 13: 14–8.
5. Shehab D, Al-Jarallah K. Nonspecific low-back pain in Kuwaiti children and adolescents: associated factors. J Adolesc Health 2005; 36 (1): 32–5.
6. Никифоров А.С., Авакян Г.Н. Неврологические осложнения остеохондроза позвоночника. М.: Медпрактика, 2011.
7. Sharma H, Gupta R, Olivero W et al. fMRI in patients with lumbar disc disease: a paradigm to study patients over time. J Pain Research 2011; 4: 401–5.
8. Hagen K, Jamtvedt G, Hilde G, Winnem M. Bed rest bad for back pain, ineffective for sciatica. The updated Cochrane Review of bed rest for low back pain and sciatica. Spine 2005; 30: 542–6.
9. van Tulder M, Becker A, Bekkering T et al. European guidelines for the management of acute nonspecific low back pain in primary care. J Eur Spine 2006; 15 (Suppl. 2): S169–S191.
10. Acute low back pain: a new paradigm for management. Editorials. BMJ 1996; 313: 1343–4.
11. Pillastrini P, Gardenghi I, Bonetti F et al. An updated overview of clinical guidelines for chronic low back pain management in primary care. Joint Bone Spine 2012; 79 (2): 176–85.
12. Helin-Salmivaara A, Saarelainen S, Gro Nroos J et al. Risk of upper gastrointestinal events with the use of various NSAIDs: A case-control study in a general population. Scandinavian. J Gastroenterol 2007; 42: 923–32.
13. Ding C. Do NSAID affect the progression of osteoarthritis? Inflammation 2002; 26: 139–42.
14. Huskinsson E, Berry P, Gishen P. Effects of anti-inflammatory drugs on the progression of osteoarthritis of the knee. J Rheumatol 1995; 22: 1941–6.
15. Бадокин В.В. Пути оптимизации терапии остеоартроза. Arta medica. 2007; 5 (26): 55–61.
16. Michel B, Bruhlmann P, Stucki G, Uebelhart D. Chondroprotection through Chondrosulf: the Zurich study. Ann Rheum Dis 2002; 61 (Suppl. 1): 116.
17. Lippielo L, Grande D. In vitro chondroprotection of glucosamine and chondroitin sulfate in a rabbit model of a OA and demonstration of metabolic synergy on chondrocyte in vitro. Ann Rheum Dis 2000; 59 (Suppl. 1): 266.
18. Lippielo L, Woodword J, Karpman D еt al. Beneficial effect of cartilage structure modyifing agents tested in chondrocyte and rabbit instability model osteoartrosis. Arthr Rheum 1999; (Suppl. 42): 256.
19. Wilkens P, Scheel I, Grundnes O et al. Effect of glucosamine on pain-related disability in patients with chronic low back pain and degenerative lumbar osteoarthritis: a randomized controlled trial. JAMA 2010; 304 (1): 45–52.
20. Jordan K, Arden N, Doherty M et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Nrials (ESCISIT). Ann Rheum Dis 2003; 62: 1145–55.
21. The efficacy of Glucosamine and Chondroitin Sulfate in Patients with Painful Knee Osteoarthritis (OA): The Glucosamine/chondroitin Arthritis Intervention Trial (GAIT). 2005 ACR/ARHP Annual Sciehtific Meeting, November 12–17, San Diego, California, №622.
22. Чебыкин А.В. Опыт применения хондропротектора Артра у пациентов с болью в спине. Неврология, нейропсихиатрия, психосоматика. 2012; 3: 67–72.
23. Leffler C, Philippi A, Leffler S еt al. Glucosamine, chondroitin, and manganese ascorbate for degenerative joint disease of the knee or low back: a randomized, double-blind, placebo-controlled pilot study. Mil Med 1999; 164 (2): 85–91.
24. Алексеев В.В. Хондропротекторы в неврологии: основания к применению. Cons. Med. 2012; 14; (9): 94–9.
Авторы
П.Р.Камчатнов1, М.А.Евзельман2
1 ГБОУ ВПО РНИМУ им. Н.И.Пирогова Минздрава России, Москва;
2 ГБОУ ВПО Орловский государственный университет
1 ГБОУ ВПО РНИМУ им. Н.И.Пирогова Минздрава России, Москва;
2 ГБОУ ВПО Орловский государственный университет
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.